Discovery And Early Development Of Mk-1064: A Potent, Orally Bioavailable, Selective Orexin 2 Receptor Antagonist (2-Sora) For The Treatment Of Insomnia Anthony J. Roecker , Swati P. Mercer , Christopher D. Cox , Mark E. Fraley , John D. Schreier , Justin T. Steen , Pamela L. Tannenbaum , Anthony L. Gotter , Susan L. Garson , Steven V. Fox , C. Meacham Harrell , Joanne Stevens , Wei Lemaire , Joseph G. Bruno , Joyce Stellabott , John D. Higgins , Tamara D. Cabalu , Dan Cui , Thomayant Prueksaritanont , George D. Hartman , Steven D. Young , Christopher J. Winrow , John J. Renger , Mark S. Forman , Paul J. Coleman ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY（2014）
AI 理解论文
溯源树
样例
